title: Early nasogastric feeding in predicted severe acute pancreatitis: A clinical, randomized study.
abstract: OBJECTIVE
  To compare the efficacy and safety of early, nasogastric enteral nutrition (EN) with total parenteral nutrition (TPN) in patients with predicted severe acute pancreatitis (SAP).
  
  
  BACKGROUND
  In SAP, the magnitude of the inflammatory response as well as increased intestinal permeability correlates with outcome. Enteral feeding has been suggested superior to parenteral feeding due to a proposed beneficial effect on the gut barrier.
  
  
  METHODS
  Fifty patients who met the inclusion criteria were randomized to TPN or EN groups. The nutritional regimen was started within 24 hours from admission and EN was provided through a nasogastric tube. The observation period was 10 days. Intestinal permeability was measured by excretion of polyethylene glycol (PEG) and concentrations of antiendotoxin core antibodies (Endocab). Interleukins (IL)-6 IL-8, and C-reactive protein (CRP) were used as markers of the systemic inflammatory response. Morbidity and feasibility of the nutritional route were evaluated by the frequency of complications, gastrointestinal symptoms, and abdominal pain.
  
  
  RESULTS
  PEG, Endocab, CRP, IL-6, APACHE II score, severity according to the Atlanta classification (22 patients), and gastrointestinal symptoms or abdominal pain did not significantly differ between the groups. The incidence of hyperglycemia was significantly higher in TPN patients (21 of 26 vs. 7 of 23; P < 0.001). Total complications (25 vs. 52; P = 0.04) and pulmonary complications (10 vs. 21; P = 0.04) were significantly more frequent in EN patients, although complications were diagnosed dominantly within the first 3 days.
  
  
  CONCLUSIONS
  In predicted SAP, nasogastric early EN was feasible and resulted in better control of blood glucose levels, although the overall early complication rate was higher in the EN group. No beneficial effects on intestinal permeability or the inflammatory response were seen by EN treatment.
authors.affiliation: Department of Surgery, Lund University Hospital, Lund, Sweden.
authors.forename: Gunilla E
authors.initials: GE
authors.lastname: Eckerwall
authors.forename: Jakob B
authors.initials: JB
authors.lastname: Axelsson
authors.forename: Roland G
authors.initials: RG
authors.lastname: Andersson
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004750:Enteral Nutrition; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007441:Intubation, Gastrointestinal; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000628:therapy*; D010288:Parenteral Nutrition; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome